,0,1
0,patent copyright trademark,9.0
1,institutional buyer,9.0
2,leaf collimator,9.0
3,clinical study,9.0
4,scanner platform,9.0
5,wall street journal,9.0
6,gantry architecture,9.0
7,executive officer,9.0
8,institutional buyers,9.0
9,definite lived intangible,8.8
10,medical practice,8.666666666666668
11,legal proceeding,8.617647058823529
12,accounting standards codification,8.551724137931036
13,feasible manner,8.545454545454545
14,allocation rate,8.507692307692308
15,funds rate,8.507692307692308
16,adverse decision,8.5
17,longer potentially outstanding,8.5
18,group purchasing organization,8.5
19,departmental spending,8.395939086294415
20,advanced fully integrated,8.380952380952381
21,exchange rate,8.344901610017889
22,japanese yen,8.333333333333334
23,madison wisconsin facility,8.258064516129032
24,embedded derivatives,8.25
25,coverage ratio,8.25
26,accounting policy,8.244031830238727
27,employee stock plan,8.211922937113776
28,borrowing rate,8.174358974358974
29,risk factors,8.147540983606557
30,financial instrument,8.147430830039525
31,closing submission,8.126436781609195
32,revenue,8.117117117117118
33,net income,8.113784907902556
34,local currency,8.088055797733217
35,legal proceeding,8.059205500381971
36,month,8.055826043901634
37,unique feature,8.055555555555555
38,owned subsidiary,8.054054054054054
39,overview products,8.054054054054054
40,alleging misappropriation,8.04945054945055
41,transition method,8.02307571349949
42,south america,8.022727272727273
43,treasury stock method,8.020411549950216
44,lived asset,8.0
45,undue reliance,8.0
46,convertible notes,7.986797837692643
47,convertible notes,7.986797837692643
48,quarterly installment,7.9818181818181815
49,month,7.978479621173685
50,major market,7.977011494252873
51,trade secret,7.968421052631578
52,tax position,7.9604037267080745
53,cowealth,7.958333333333333
54,financial institution,7.94113712374582
55,generation tomotherapy,7.91
56,accuray wa liable,7.903857745629898
57,tradeshow,7.891385767790263
58,supporting evidence,7.888888888888889
59,month,7.878832354859752
60,total debt,7.869565217391305
61,tumor,7.867924528301887
62,senior notes,7.859138263224558
63,price besp,7.851347517730496
64,stage cancer,7.835555555555555
65,asset valuation,7.8
66,intangible asset,7.8
67,intangible asset,7.8
68,process selling,7.799999999999999
69,libor rate floor,7.793406593406593
70,exchange rate,7.786460051576331
71,service plan costs,7.775219298245615
72,party evidence tpe,7.7727272727272725
73,wa primarily due,7.765654873254054
74,america region,7.746411483253589
75,accounting policy,7.744031830238727
76,term debt,7.741418764302059
77,conversion rate,7.73183023872679
78,foreign currency,7.689271891230277
79,capital expenditure requirements,7.673758865248227
80,stock price,7.6708895024633215
81,net loss,7.651080945198592
82,anti dilutive additionally,7.647058823529411
83,edge technology,7.631578947368421
84,debt instrument,7.624725516029863
85,hospital group,7.618055555555555
86,retrospective approach,7.617647058823529
87,comprehensive loss,7.6139194139194135
88,similar expression,7.612159329140461
89,subsequent events,7.604651162790698
90,misappropriation,7.602307692307693
91,term success,7.596491228070176
92,international court,7.586956521739131
93,business strategy plan,7.5677655677655675
94,early adoption,7.567460317460318
95,cost submission,7.553516819571866
96,contracted maturity,7.538796229151559
97,wa partially offset,7.530362561039208
98,development project,7.528070175438597
99,security law,7.526578827805543
100,operating decision,7.506578947368421
101,bank certificate,7.5
102,harbor provision,7.5
103,accrual wa established,7.472310126582279
104,tomohda,7.467567567567568
105,exchange expense,7.452868821493873
106,balance sheet arrangements,7.446511627906977
107,conversion rate,7.441507658081629
108,unrealized gain,7.44110576923077
109,exchange loss,7.439098641057026
110,stock exceeds,7.436961339571534
111,sale agreement,7.434025524551157
112,original maturity,7.428571428571429
113,fewer system,7.408865979381443
114,average number,7.407407407407407
115,allocated expense,7.4000398247710075
116,deemed past due,7.395939086294416
117,loss position,7.375696767001115
118,exchange agreement,7.372284201850609
119,realized loss,7.360763267740012
120,balance sheet,7.3556025369978855
121,principal amount,7.35241397946316
122,conversion price,7.345162868119818
123,share price,7.332251472532755
124,development activity,7.332236842105264
125,actual performance,7.327561327561327
126,inventory purchasing activity,7.324074074074074
127,cash flow,7.319640564826701
128,customers,7.292307692307693
129,software license agreement,7.285902503293808
130,share count,7.278046811945117
131,dilutive share,7.273845131272848
132,dilutive share,7.273845131272848
133,recurring adjustment,7.2729885057471275
134,financial statement,7.270922382734618
135,legal fee,7.250248410174881
136,component,7.248447204968944
137,credit risk,7.230874316939891
138,credit risk,7.230874316939891
139,investment category,7.228
140,manufacture sell,7.227564102564102
141,operating lease,7.217785843920145
142,income tax expense,7.215027256693923
143,equity revenues,7.2076271186440675
144,income loss,7.204828504828505
145,company design,7.190718372536554
146,tax,7.190581943437274
147,equity investment,7.185627118644067
148,july fasb approved,7.1840909090909095
149,training revenue,7.183973447131342
150,manner inability,7.17878787878788
151,market data,7.1770114942528735
152,account receivable,7.176456984273821
153,income tax benefit,7.170612923661704
154,financial instruments,7.161172901921132
155,deferred rent,7.157843848199178
156,radiation therapy system,7.1554188480395755
157,financing receivables,7.148958333333333
158,income tax,7.140619515619515
159,doubtful account,7.132019927536232
160,robotic system,7.128865979381443
161,payment term,7.1246963562753045
162,conversion component,7.115442278860569
163,service contract signing,7.11311612364244
164,principal amount,7.099044707225963
165,sale price,7.094998229687951
166,legal fee,7.094549232736573
167,financial position,7.091386382280557
168,capital management,7.08709219858156
169,insurance expense,7.082515849182515
170,consulting expense,7.082451499118166
171,conversion rate,7.076657824933687
172,loan matures,7.074074074074074
173,capital requirement,7.071194762684124
174,account receivable,7.0677613320999075
175,asset,7.0675675675675675
176,actual condition,7.060982495765105
177,convertible notes,7.054365405260211
178,hedging activity,7.04054054054054
179,related cost,7.0369860224704155
180,net revenue,7.031297281936668
181,cowealth,7.029761904761904
182,channel sale,7.025162648296977
183,product development,7.023602821486707
184,foreign location,7.0124804396778755
185,revenue recognition,7.011976326623705
186,quoted price,7.011347517730496
187,business plan,7.0093240093240095
188,asu defines,6.994312704839021
189,earlier repurchased redeemed,6.9889705882352935
190,remaining change,6.986920516192669
191,significant judgment,6.983333333333333
192,conversion price,6.980313034971875
193,hearing wa held,6.972310126582279
194,final payment,6.971763262118592
195,report statements,6.967741935483871
196,revenue recognition process,6.966913035484463
197,lower margin,6.9615761519314825
198,interest method,6.9606221935414485
199,stock price,6.956603788177606
200,common share,6.955466166783827
201,note wa redeemed,6.952877353473035
202,maturity date,6.951552795031056
203,consolidated statement,6.9451698743734145
204,channel sale,6.941829314963643
205,fasb issued asu,6.9385198135198145
206,management,6.937142857142858
207,accounting estimate,6.936339522546419
208,pricing method,6.9275362318840585
209,interest rate maturity,6.926059654631082
210,pcs revenue,6.907657657657658
211,loss account,6.907397674788979
212,stereotactic body,6.904166666666667
213,service cost,6.896062372643735
214,convertible note,6.895394107009892
215,principal amount,6.8912102086147184
216,net order,6.8906890848067315
217,geographic region,6.889077865050406
218,material change,6.883928571428571
219,interim period,6.883173076923077
220,debt recovery,6.878260869565217
221,net loss,6.875800046322187
222,rotary systems,6.872302158273381
223,revenue recognition assessment,6.8677826007018545
224,side effect,6.857777777777779
225,cancer care group,6.851428571428571
226,guidance,6.838541666666666
227,quarter,6.8318555008210184
228,management,6.83
229,principal amount,6.828604455653636
230,tax expense,6.819770339697876
231,radiosurgery treatment,6.8184523809523805
232,part revenue,6.817117117117117
233,factor,6.806603773584905
234,debt security,6.793896455231112
235,series systems production,6.788968824940048
236,tax,6.7873511904761905
237,early adoption,6.781746031746032
238,amortization expense,6.776813271604938
239,additional amount,6.775719028844158
240,net revenue,6.775331279975243
241,radiation oncology company,6.772364796288241
242,system revenue training,6.772298885972245
243,service revenue,6.7524554629817795
244,faith belief,6.75
245,clearance license,6.7478590250329376
246,product revenue,6.745983096498561
247,net change,6.745346055088701
248,financial asset,6.744021739130435
249,slight offset,6.729927434456929
250,debt issuance net,6.728409413831408
251,term investment,6.7152958257713244
252,asset amortization,6.708061002178649
253,service cost,6.706873183454546
254,revenue conversion process,6.7012550481516
255,area revenue,6.6957124348428705
256,consulting expense,6.694770339697876
257,operation rate,6.687556561085973
258,common stock,6.680204582814778
259,decrease wa primarily,6.6800606145458445
260,offering cost,6.677772771952817
261,maturity date,6.665838509316771
262,condition change,6.652571522680217
263,increase wa primarily,6.651122822135516
264,low risk,6.647540983606557
265,system revenue,6.641922182792977
266,greater awareness,6.639285714285714
267,moderate risk,6.638612412177986
268,prior year,6.637942625153815
269,financial position,6.637723785166241
270,valuation allowance assessment,6.635869565217391
271,marketing expense,6.634363129154796
272,financial statement,6.628498140310375
273,company,6.624056773266259
274,benefit cost,6.617744461848288
275,interest expense,6.613137686636652
276,service contract,6.61311612364244
277,sell advanced radiosurgery,6.604166666666666
278,financial asset,6.604140786749483
279,service revenue,6.60380681433313
280,current period,6.591051684801686
281,loan interest,6.588010204081632
282,solely share,6.574750108648413
283,equity conversion component,6.5730693975046375
284,license,6.567424242424242
285,intangible assets,6.566666666666666
286,system sale agreement,6.562891503932601
287,primarily market,6.561917154630232
288,stock option,6.557861312463917
289,additional equity,6.550960451977401
290,credit loss,6.550080128205128
291,worldwide basis,6.543956043956044
292,quoted price,6.542116748499727
293,revenue,6.538604720422902
294,revenue,6.538604720422902
295,financial performance,6.5247757073844035
296,gross profit,6.5217426392457
297,exchange commission,6.516763895582619
298,net age,6.509204930917515
299,cowealth,6.505048221820374
300,decrease,6.495154954168486
301,million primarily due,6.493927795591001
302,million due primarily,6.493927795591001
303,lease obligation,6.468852700250159
304,increase wa driven,6.466217161758157
305,supplier,6.463131804903957
306,cash flow,6.462497707683843
307,management doe,6.460952380952381
308,service cost,6.460784989997931
309,service revenue,6.4481076368948225
310,award amount,6.445631107163046
311,million primarily related,6.436530375963251
312,million related primarily,6.436530375963251
313,conversion share,6.430756171551028
314,debt issuance cost,6.425717083076476
315,annual period,6.422916666666667
316,training revenue,6.421210684368579
317,subsidiary liquidity,6.416627153469259
318,year,6.4163381061077684
319,revenue recognition criterion,6.406913035484464
320,secret claim,6.405921052631578
321,increase wa related,6.404758828424825
322,infringes,6.4
323,note,6.386618283677108
324,inventory decrease,6.384418901660281
325,radixact system,6.378865979381443
326,estimable loss,6.375837703962704
327,effective date,6.37579521927348
328,body,6.371428571428572
329,fixed charge,6.362984218077475
330,currency impact,6.360834518729256
331,system,6.350353582687228
332,million resulting primarily,6.341231952539829
333,market participant assumption,6.33415435139573
334,intangible asset,6.326315789473684
335,decrease,6.319874055292081
336,equipment net,6.315836479519343
337,management judgment,6.3133333333333335
338,share settlement,6.310446438462391
339,market inputs,6.310344827586207
340,cash resource,6.30836236933798
341,combination settlement feature,6.304166666666667
342,larger tumor,6.2995283018867925
343,annum,6.298924731182796
344,gross profit,6.292654293381037
345,prior year,6.292003538859398
346,cost,6.291612057667104
347,increase wa offset,6.290936262881754
348,fiscal quarter,6.285129310344828
349,fiscal year,6.276236711600636
350,year selling,6.274678270042195
351,system sale,6.262656486306279
352,sale type lease,6.262468445947602
353,cash flows,6.261753027926996
354,million partially offset,6.258635483376155
355,maturity date,6.25262806384826
356,service cost component,6.246826179929281
357,incise mlc clinician,6.241379310344827
358,location reduction,6.216541353383459
359,sale transaction,6.213127908842882
360,product line,6.203865979381443
361,arbitration,6.198380566801619
362,june,6.191721892803162
363,sale debt security,6.185709541697514
364,performance obligation,6.175438596491229
365,cash flows,6.170184914055525
366,remaining million related,6.169806533767711
367,company classifies,6.159410308619795
368,significant benefit,6.158167036215817
369,revenue contract,6.157394894894895
370,year period,6.148253538859398
371,measurement period,6.141089881898706
372,accrual reduction,6.134722222222223
373,million fee,6.132874715585893
374,installation revenue,6.124324324324324
375,balance sheet arrangement,6.113178294573644
376,note holder,6.112553038092875
377,probable loss,6.104395604395604
378,common share,6.0983233096409695
379,year beginning,6.084678270042194
380,commission expense,6.064926128314107
381,related note,6.060907536091359
382,depreciation expense,6.051945546737214
383,bonus payment,6.0515026192445545
384,product cost,6.044701639533018
385,product,6.033929270520684
386,share amount,6.031559692507178
387,revenue recognition,6.031155459726889
388,service contract deferral,6.029782790309107
389,cash amount,6.028541916566707
390,hospital,6.023326841830817
391,purchase price,6.018036480941198
392,early payment,6.013510399346577
393,equipment sale,6.0095948827292105
394,system revenue,6.007887858403322
395,cash flow,6.007140564826701
396,cyberknife system,5.98835846058445
397,net cash,5.987178378107812
398,fiscal quarter,5.9766877519032695
399,level input,5.956456456456456
400,percentage revenue,5.9552813683248464
401,contract range,5.9474250296235525
402,office,5.944197953268555
403,november cowealth,5.944047619047619
404,measurement date level,5.940827784306045
405,cyberknife system,5.92585846058445
406,cyberknife systems receipt,5.919294639476389
407,credit loss,5.899038461538462
408,cash cash,5.881162428645563
409,additional financing,5.8785661764705885
410,company,5.8773699562469615
411,period age,5.854137555482493
412,item management,5.847441860465116
413,inability,5.847079964061097
414,stock subject,5.8316981816767965
415,tomotherapy systems,5.792302158273381
416,states dollar,5.771712158808933
417,remaining approximately million,5.758975710474539
418,cyberknife system order,5.7531311878571785
419,business,5.7344322344322345
420,net property,5.6903105328152765
421,asset liability revenue,5.647551899725813
422,company lease office,5.625341558681038
423,credit quality,5.572222222222223
424,market activity,5.560344827586206
425,approximately million accuray,5.559841511340339
426,liability,5.554634626480671
427,company,5.548773116667248
428,result litigation,5.547720183181788
429,accrued interest,5.538593253000859
430,sale investment change,5.502475835110164
431,radiosurgery treatment,5.472298534798535
432,company,5.47099533888947
433,repurchase approximately million,5.440793892292721
434,sale contract,5.439753612887941
435,lease obligation,5.411070780399275
436,quarter presentation,5.40436632333184
437,manufacture,5.394230769230769
438,customer transfer,5.37636897789182
439,senior notes,5.3604040860093685
440,foreign exchange,5.310893512851898
441,timely manner,5.245454545454546
442,cash,5.241654294803817
443,premium share,5.1659588998572055
444,financial instrument,5.147430830039525
445,year decrease,5.1450230976284015
446,longer infringes,5.142857142857142
447,year increase,5.116085305218074
448,income tax,5.073051948051948
449,count alleging,5.049450549450549
450,item cancellation age,5.028094170572828
451,radiation therapy,5.026552868658133
452,wa offset,5.009529227705874
453,short term,4.987295825771325
454,convertible notes,4.986797837692643
455,primarily driven,4.9849056603773585
456,primarily due,4.9808447466717745
457,trade secret,4.968421052631578
458,outstanding amount,4.967798594847775
459,financial institution,4.941137123745819
460,legal accrual,4.930147058823529
461,greater awareness,4.925
462,applicable margin,4.923963133640553
463,legal fee,4.898897058823529
464,unrealized loss,4.897435897435898
465,foreign currency,4.852062588904694
466,hedging instrument,4.840909090909091
467,legal cost,4.837830545062062
468,consolidated basis,4.837662337662338
469,geographic region,4.821510297482838
470,quoted price,4.811347517730496
471,intangible asset,4.8
472,doubtful account,4.793478260869565
473,libor rate,4.793406593406593
474,original maturity,4.785714285714286
475,fasb approved,4.784090909090909
476,prepaid tax,4.782142857142857
477,arbitrator interest,4.775510204081632
478,separate accounting,4.773946360153257
479,financial condition,4.768642951251646
480,primarily consisted,4.758818703855619
481,partially offset,4.745552434456929
482,comparable price,4.74468085106383
483,agreement,4.733954451345756
484,recognition measurement,4.7330391616105905
485,conversion rate,4.73183023872679
486,asc debt,4.728260869565217
487,conversion feature,4.724137931034482
488,additional equity,4.717627118644067
489,accounts,4.716312056737589
490,reference rate,4.707692307692308
491,capital resource,4.697568389057751
492,twelve month,4.688356164383562
493,company,4.684570652225011
494,account,4.676456984273821
495,capital expenditure,4.673758865248227
496,advanced capability,4.666666666666666
497,expense net,4.6648511256354395
498,significant item,4.662790697674419
499,court,4.658385093167702
500,cash flows,4.6571018651362985
501,unique benefit,4.6531165311653115
502,net loss,4.651080945198592
503,bunker construction,4.65
504,significant risk,4.647540983606557
505,anti dilutive,4.647058823529411
506,training revenue,4.643432906590801
507,total leverage,4.641304347826087
508,net revenue,4.639992934110581
509,consulting fee,4.638392857142858
510,conversion price,4.635485448764979
511,professional service,4.635338345864662
512,common equity,4.635046473482777
513,net amount,4.633531554698382
514,tax expense,4.624118165784832
515,compensation cost,4.620183486238532
516,comprehensive loss,4.6139194139194135
517,fewer project,4.613333333333333
518,revenue recognition,4.606913035484464
519,aggregate materially,4.60377358490566
520,topic,4.6
521,marketing selling,4.593846153846154
522,income taxes,4.590909090909091
523,related activity,4.588541666666666
524,primarily impacted,4.584905660377359
525,geographic area,4.578595317725753
526,moderate risk,4.576112412177986
527,additional accrual,4.5725
528,early adoption,4.567460317460317
529,cancer type,4.565714285714286
530,financial asset,4.556521739130435
531,similar asset,4.555555555555555
532,similar technique,4.555555555555555
533,development expense,4.536712150747238
534,bonus,4.534722222222222
535,management,4.534545454545455
536,continued amortization,4.534391534391535
537,system,4.533929270520684
538,loss,4.533268419344369
539,aggregate basis,4.532345013477089
540,service,4.531277432159078
541,development project,4.528070175438597
542,foreign subsidiary,4.527738264580369
543,month volatility,4.521689497716895
544,basis,4.511904761904762
545,prime rate,4.507692307692308
546,regulatory clearance,4.505434782608695
547,decreased due,4.5012022441891535
548,pricing model,4.5
549,international chamber,4.5
550,hedging activity,4.5
551,previously anticipated,4.5
552,principal amount,4.495271122320302
553,convertible note,4.490330815870652
554,marketing program,4.487179487179487
555,tax,4.482142857142858
556,tax audit,4.482142857142858
557,fewer unit,4.48
558,debt,4.478260869565217
559,facility cost,4.478248002367565
560,market participant,4.477011494252873
561,related service,4.473880012531328
562,related receivables,4.471875
563,debt,4.469857508220679
564,tomohda,4.467567567567567
565,exchange commission,4.4601601219977125
566,equity section,4.4576271186440675
567,customer purchase order,4.453824855347698
568,balance sheet,4.446511627906977
569,prepaid expense,4.441975308641975
570,support current,4.441558441558442
571,current gaap,4.441558441558442
572,current asset,4.441558441558442
573,amortization expense,4.438271604938272
574,common stock,4.436961339571534
575,previously aged,4.434065934065934
576,sale agreement,4.434025524551157
577,capital lease,4.426632428466618
578,financial assets,4.423188405797101
579,interest expense,4.417485512723609
580,contractual agreement,4.415273132664437
581,exit price,4.411347517730496
582,trading price,4.411347517730496
583,term risk,4.4106988783434
584,net change,4.406804388422035
585,costs,4.401785714285714
586,insurance,4.4
587,financing receivable,4.398603723404255
588,fourth quarter,4.391379310344828
589,sale organization,4.390547263681592
590,gross profit,4.386404293381037
591,principal place,4.384615384615385
592,united states,4.384615384615385
593,channel mix,4.384615384615385
594,significant change,4.383928571428571
595,contract,4.382841068917019
596,current year,4.382486711600635
597,operating activity,4.381578947368421
598,functional currency,4.378378378378379
599,individual negotiation,4.375
600,established reliability,4.375
601,sale tax,4.3726901208244495
602,rotary systems,4.372302158273381
603,market development,4.371748336358137
604,trade show,4.368421052631579
605,financial statement,4.361831473643709
606,minimum amount,4.360655737704918
607,revenue,4.36036036036036
608,step process,4.359999999999999
609,process improvement,4.359999999999999
610,service cost,4.355521832103194
611,legal matter,4.350980392156863
612,radiation beam,4.350877192982456
613,net order,4.350148544266191
614,lease term,4.349364791288567
615,equity component,4.348931466470155
616,asu recognition,4.348770277341706
617,current period,4.347808441558442
618,initial purchaser,4.344827586206897
619,gross amount,4.343213877239801
620,variable rate,4.341025641025641
621,working capital,4.340425531914894
622,capital resources,4.340425531914894
623,cost,4.339231105286151
624,related repurchase,4.338541666666666
625,year,4.336867356336611
626,final award,4.334975369458128
627,vendor advance,4.333333333333334
628,day,4.333333333333334
629,offsetting gain,4.333333333333334
630,existing order,4.327272727272727
631,secured leverage,4.324074074074074
632,cash flow,4.319640564826701
633,active market,4.310344827586207
634,cash resource,4.30836236933798
635,interim period,4.30625
636,wa million,4.297893175501505
637,marketing expense,4.29582146248813
638,debt security,4.295162278015922
639,account payable,4.293478260869565
640,account,4.293478260869565
641,anticipated risk,4.2903981264637
642,cash,4.289761178861788
643,regulatory requirement,4.2842809364548495
644,neck cancer,4.279999999999999
645,fully settled,4.276785714285714
646,additional financing,4.275625
647,unpaid interest,4.275510204081632
648,interest,4.275510204081632
649,court,4.274456521739131
650,america gaap,4.272727272727273
651,combination,4.270833333333334
652,loss expense,4.270180436847104
653,annual report,4.266666666666667
654,financing activity,4.265625
655,term,4.2631578947368425
656,month,4.259784735812133
657,service office,4.252985404688191
658,service revenue,4.252455462981779
659,generated primarily,4.251572327044025
660,economic activity,4.25
661,fee,4.247916666666667
662,license,4.242424242424242
663,prior year,4.242003538859398
664,incise mlc,4.241379310344827
665,transaction price,4.233928162891787
666,radiosurgery system,4.23303264604811
667,focal area,4.230769230769231
668,adjustment,4.230195712954334
669,related disclosure,4.229846014492754
670,operating lease,4.217785843920145
671,irrevocably elect,4.214285714285714
672,credit loss,4.211538461538462
673,collaboration agreement,4.210144927536232
674,licensing agreement,4.210144927536232
675,equity,4.2076271186440675
676,prior period,4.207325268817204
677,general requirement,4.203846153846154
678,service,4.202905913432229
679,observable input,4.2
680,system,4.191365979381443
681,year beginning,4.190928270042194
682,omitted pursuant,4.190476190476191
683,request prior,4.189964157706093
684,quarterly report,4.181818181818182
685,revenue,4.172672672672673
686,incise mlcs,4.172413793103448
687,continued adoption,4.166666666666667
688,partii item,4.162790697674419
689,parti item,4.162790697674419
690,report profit,4.153846153846153
691,marketing initiative,4.153846153846153
692,tumor type,4.153638814016173
693,additional disclosure,4.151304347826087
694,financing receivables,4.148958333333333
695,cost basis,4.1487549148099605
696,cancer tumor,4.147924528301886
697,risk,4.147540983606557
698,high risk,4.147540983606557
699,development research,4.144736842105264
700,contract,4.144444444444444
701,anticipated driver,4.142857142857142
702,location,4.142857142857142
703,administrative expense,4.1419753086419755
704,supply expense,4.1419753086419755
705,contractual term,4.134952766531714
706,operating asset,4.131578947368421
707,regulatory qualification,4.130434782608695
708,regulatory approval,4.130434782608695
709,radixact system,4.128865979381443
710,smart system,4.128865979381443
711,material loss,4.128205128205128
712,reporting unit,4.125
713,radixact systems,4.122302158273381
714,accuray breached,4.119047619047619
715,report accuray,4.119047619047619
716,accuray incorporated,4.119047619047619
717,ii retrospective,4.117647058823529
718,recognize revenue,4.117117117117117
719,revenue,4.117117117117117
720,revenue prospect,4.117117117117117
721,rotary settlement,4.116666666666667
722,cash item,4.114010209869541
723,service contract,4.11311612364244
724,cowealth litigation,4.112179487179487
725,payment activity,4.111538461538462
726,maximum amount,4.110655737704918
727,notional amount,4.110655737704918
728,quarterly basis,4.1103896103896105
729,judgment,4.108333333333333
730,underlying transaction,4.108294930875576
731,decreased salary,4.105263157894736
732,radiosurgery conducted,4.104166666666666
733,net proceeds,4.103520978283786
734,asu measurement,4.1022176022176025
735,billing resulting,4.100386100386101
736,march,4.098239110287303
737,million primarily,4.097988709296585
738,decrease,4.0951549541684855
739,anticipated cash,4.094076655052264
740,differ materially,4.086956521739131
741,court,4.086956521739131
742,minnesota court,4.086956521739131
743,district court,4.086956521739131
744,lease inception,4.086206896551724
745,lease extension,4.086206896551724
746,lessee,4.084905660377359
747,credit,4.083333333333334
748,credit enhancement,4.083333333333334
749,credit losses,4.083333333333334
750,accrued severance,4.083333333333334
751,current quarter,4.082937751903269
752,thousand debt,4.082912032355915
753,market,4.08117816091954
754,management,4.08
755,cowealth,4.0773809523809526
756,foreign operation,4.076625386996904
757,secured loan,4.074074074074074
758,early adopt,4.067460317460317
759,conversion obligation,4.066243194192378
760,increase wa,4.066217161758158
761,generally span,4.0625
762,governed generally,4.0625
763,generally governed,4.0625
764,gross order,4.059830866807611
765,objective forward,4.056603773584905
766,update forward,4.056603773584905
767,derived principally,4.055555555555555
768,measurement date,4.051938895417156
769,administrative general,4.05
770,ha determined,4.049507735583685
771,specific identification,4.0476190476190474
772,intercompany balance,4.046511627906977
773,disclosure requirement,4.045150501672241
774,current operation,4.04449961802903
775,liquidity requirement,4.042735042735043
776,order,4.041558441558442
777,tomotherapy system,4.038865979381443
778,wa received,4.034810126582279
779,forward contract,4.034381551362683
780,tomotherapy systems,4.032302158273382
781,trading day,4.032258064516129
782,share amount,4.031559692507178
783,period,4.03125
784,net age,4.029204930917515
785,accrued interest,4.025510204081632
786,investment amortization,4.0242962962962965
787,actual result,4.024199843871975
788,litigation settlement,4.02051282051282
789,lower headcount,4.018018018018018
790,contractual maturity,4.014652014652015
791,significant impact,4.008771929824562
792,increased installation,4.007207207207207
793,primarily denominated,4.001572327044025
794,sunnyvale california,4.0
795,rulesand regulation,4.0
796,necessarily indicative,4.0
797,core principle,4.0
798,promised good,4.0
799,practical expedient,4.0
800,reserve,4.0
801,exercise,4.0
802,money,4.0
803,rely exclusively,4.0
804,inherently unpredictable,4.0
805,significant uncertainty,4.0
806,named defendant,4.0
807,appeals,4.0
808,hong kong,4.0
809,clerical error,4.0
810,subsequently issue,4.0
811,action,4.0
812,adjusted ebitda,4.0
813,perspective,4.0
814,injunctive relief,4.0
815,report,4.0
816,good candidate,4.0
817,considerably wider,4.0
818,cell,4.0
819,multiple site,4.0
820,designed specifically,4.0
821,safety efficacy,4.0
822,beam angle,4.0
823,dose,4.0
824,varies significantly,4.0
825,renovate,4.0
826,properly executed,4.0
827,work closely,4.0
828,administrative involvement,4.0
829,swiss franc,4.0
830,indefinitely reinvested,4.0
831,thereon,4.0
832,competing technological,4.0
833,historical experience,4.0
834,asset,4.0
835,homogenous nature,4.0
836,discovery,4.0
837,priority lien,4.0
838,specifically designed,4.0
839,tomoh tomohd,4.0
840,automated workflow,4.0
841,commercial launch,4.0
842,swiss authority,4.0
843,januaryand augustof,4.0
844,manufacturing space,4.0
845,detail schedule,4.0
846,administrative agent,4.0
847,radixact testing,4.0
848,accompanying note,3.991596638655462
849,training point,3.9878542510121457
850,fewer age,3.9863291139240506
851,deferred cost,3.982088248143294
852,higher percentage,3.9782608695652173
853,contract,3.977777777777778
854,executed contract,3.977777777777778
855,written contract,3.977777777777778
856,advantageous market,3.9770114942528734
857,asu revenue,3.9760914760914763
858,lower commission,3.9743021710234823
859,treatment facility,3.9723502304147464
860,current liability,3.971993224167137
861,related product,3.96740764604811
862,cowealth,3.958333333333333
863,system order,3.956138706654171
864,repayment requirement,3.953846153846154
865,maturity date,3.9515527950310556
866,cash,3.951219512195122
867,cash receipts,3.951219512195122
868,cash receipt,3.951219512195122
869,current guidance,3.9415584415584415
870,recent year,3.9409282700421944
871,previous year,3.9409282700421944
872,institution,3.9401709401709404
873,revenue transaction,3.9396977622784073
874,large tumor,3.930424528301887
875,cash,3.9299429164504414
876,future event,3.9298642533936654
877,outpatient basis,3.928571428571429
878,nonrecurring basis,3.928571428571429
879,lease obligation,3.928312159709619
880,cyberknife system,3.925858460584451
881,prepaid commission,3.922950819672131
882,higher volume,3.9229249011857705
883,inventory transfer,3.92022792022792
884,cyberknife systems,3.919294639476389
885,foreign earnings,3.9181286549707606
886,cash,3.9178861788617887
887,adverse determination,3.916666666666667
888,reason,3.913746630727763
889,million driven,3.9130830489192263
890,wider range,3.9130434782608696
891,wide range,3.9130434782608696
892,tomotherapy,3.91
893,investment,3.9098181818181814
894,multiple element,3.909090909090909
895,respective element,3.909090909090909
896,million due,3.9090221352136427
897,period,3.90625
898,potential impairment,3.9
899,temporary impairment,3.9
900,impairment charge,3.9
901,increased cancellation,3.8995148995148994
902,sale,3.890547263681592
903,sale agent,3.890547263681592
904,adequate liquidity,3.888888888888889
905,level input,3.888888888888889
906,matter litigation,3.887179487179487
907,material change,3.883928571428571
908,fundamental change,3.883928571428571
909,limitation change,3.883928571428571
910,disclosure,3.882900986481549
911,june,3.880473127204814
912,deferred revenue,3.879021879021879
913,distributor agreement,3.8768115942028984
914,related upgrade,3.8742559523809526
915,cash share,3.872123466997382
916,financial covenant,3.8690217391304347
917,liability,3.868976449275362
918,late october,3.8680555555555554
919,statement,3.8678097345132745
920,company classifies,3.8659320477502295
921,amount,3.860655737704918
922,amount,3.860655737704918
923,loss,3.858974358974359
924,year deferral,3.857594936708861
925,change,3.851670506912442
926,million related,3.851624715585893
927,initial application,3.8448275862068964
928,cancer patient,3.8406060606060604
929,future result,3.83921815889029
930,forward percentage,3.8392124692370797
931,fewer cancellation,3.838974358974359
932,fiscal year,3.834678270042194
933,contingent asset,3.833333333333333
934,remaining million,3.8312648671010447
935,effective period,3.8304924242424243
936,management belief,3.83
937,payment,3.8292803970223326
938,order growth,3.827272727272727
939,higher technology,3.8272311212814643
940,company,3.8265508944450257
941,assumption,3.824884792626728
942,orderly transaction,3.82258064516129
943,corporate transaction,3.82258064516129
944,strategic transaction,3.82258064516129
945,transaction,3.82258064516129
946,agency security,3.816901408450704
947,cash payment,3.8127579737335835
948,large research,3.8125
949,trustee holders,3.8108108108108105
950,participating holders,3.8108108108108105
951,determinable date,3.8086956521739133
952,factor,3.806603773584906
953,statement,3.8053097345132745
954,revenue,3.8046171171171173
955,permitted starting,3.8
956,approved sale,3.799638172772501
957,total number,3.7987117552334944
958,issuance,3.794840294840295
959,management doe,3.7942857142857145
960,increased demand,3.7905405405405403
961,minimum deposit,3.7884615384615383
962,underlying exposure,3.7857142857142856
963,revenue,3.783783783783784
964,revenue,3.783783783783784
965,fiscal liquidity,3.782638888888889
966,discount rate,3.7755494505494505
967,additional million,3.773083048919226
968,party,3.7727272727272725
969,party analyst,3.7727272727272725
970,commission expense,3.764926128314107
971,ongoing basis,3.761904761904762
972,patient advances,3.7606060606060607
973,million resulting,3.75632629216247
974,numerous factor,3.75
975,debt discount,3.74611801242236
976,product revenue,3.7459830964985605
977,customer advance,3.744500846023689
978,assumption change,3.741071428571429
979,year criterion,3.740928270042194
980,million offset,3.737802150042822
981,icc ruled,3.736842105263158
982,commission amount,3.7336065573770494
983,additional installation,3.7266666666666666
984,distributor channel,3.717948717948718
985,shipping address,3.7142857142857144
986,historical fact,3.7142857142857144
987,treatment session,3.7142857142857144
988,surgical treatment,3.7142857142857144
989,treatment room,3.7142857142857144
990,site doe,3.7142857142857144
991,maintaining fda,3.7142857142857144
992,statute expiration,3.7142857142857144
993,contractual obligation,3.7139001349527665
994,sale transaction,3.7131279088428824
995,sale security,3.7074486721322963
996,greater number,3.7074074074074073
997,generally determined,3.7069444444444444
998,customer account,3.7046457735599208
999,goodwill,3.700228832951945
1000,integral part,3.7
1001,consigned part,3.7
1002,qibs pursuant,3.6904761904761907
1003,credit quality,3.6833333333333336
1004,company,3.671487603305785
1005,customer facility,3.669232028819388
1006,annum equal,3.666666666666667
1007,conversion option,3.6653144016227177
1008,system,3.6645802650957293
1009,time,3.6550000000000002
1010,letter,3.6545454545454548
1011,additional fund,3.6446153846153844
1012,market capitalization,3.6436781609195403
1013,calendar quarter,3.6413793103448278
1014,table,3.6382978723404253
1015,table,3.6382978723404253
1016,table show,3.6382978723404253
1017,million offering,3.6321306679668455
1018,million revenue,3.6302001660363437
1019,product effects,3.6288659793814433
1020,company,3.62603305785124
1021,dollar,3.6251920122887866
1022,precisely conform,3.625
1023,separate ruling,3.6222222222222222
1024,holder,3.6222222222222222
1025,tender award,3.6206896551724137
1026,revenue deal,3.6171171171171173
1027,amount,3.610655737704918
1028,company,3.608987603305785
1029,specific patient,3.608225108225108
1030,damage,3.6077724358974357
1031,thousand unaudited,3.604651162790698
1032,considered aged,3.6032388663967616
1033,binding arbitration,3.602564102564102
1034,permit,3.6
1035,management,3.595625
1036,variable include,3.5933333333333333
1037,installation revenue,3.583783783783784
1038,recorded based,3.5831925675675675
1039,time,3.5810752688172043
1040,decreased installation,3.571929824561403
1041,million general,3.5630830489192262
1042,patient faster,3.5606060606060606
1043,counterclaim including,3.556603773584906
1044,deemed essential,3.5555555555555554
1045,compliance level,3.5555555555555554
1046,order volume,3.5545454545454547
1047,excluded due,3.5538338231365216
1048,system,3.5531084036238676
1049,signed contract,3.549206349206349
1050,property plant,3.5483870967741935
1051,customer receivables,3.5445008460236886
1052,june,3.5429774036331416
1053,loss information,3.5356125356125356
1054,fiscal quarter,3.5351293103448276
1055,expiration date,3.5229813664596272
1056,recorded directly,3.515625
1057,difference,3.515625
1058,sale commission,3.5134980833537233
1059,million provided,3.5130830489192264
1060,product change,3.512794550810015
1061,factor,3.51
1062,material impact,3.5087719298245617
1063,considered equivalent,3.5050391937290035
1064,adjustment holders,3.500465983224604
1065,identical asset,3.5
1066,readily accessible,3.5
1067,physician,3.5
1068,adequately treat,3.5
1069,assurance,3.5
1070,guidance simplifies,3.5
1071,responsibility,3.5
1072,government security,3.483568075117371
1073,slight decrease,3.4770114942528734
1074,delivery,3.4545454545454546
1075,dismissal,3.4545454545454546
1076,dismissal,3.4545454545454546
1077,permitted beginning,3.45
1078,slight increase,3.448073701842546
1079,undistributed earnings,3.4444444444444446
1080,approximately million,3.4407938922927204
1081,unspecified claim,3.4375
1082,premium share,3.435189669087974
1083,million share,3.4339870037214864
1084,revenue,3.432906590801328
1085,revenue,3.432906590801328
1086,fair market,3.43289384719405
1087,temporarily impaired,3.428571428571429
1088,goodwill impairment,3.4263157894736844
1089,extent,3.4242424242424243
1090,liability component,3.4217391304347826
1091,company,3.421487603305785
1092,company,3.421487603305785
1093,company,3.421487603305785
1094,company,3.421487603305785
1095,company,3.421487603305785
1096,company,3.421487603305785
1097,company,3.421487603305785
1098,company,3.421487603305785
1099,company,3.421487603305785
1100,company,3.421487603305785
1101,company,3.421487603305785
1102,company,3.421487603305785
1103,written amendment,3.4210526315789473
1104,march,3.420724317387895
1105,acquisition,3.416666666666667
1106,contract,3.415277777777778
1107,collection effort,3.4117647058823533
1108,customer,3.4111675126903553
1109,customer licensee,3.4111675126903553
1110,potential customer,3.4111675126903553
1111,customer,3.4111675126903553
1112,sufficient number,3.4074074074074074
1113,operating result,3.3938740293356346
1114,expectation,3.3899371069182394
1115,period,3.3890086206896552
1116,concentration,3.3846153846153846
1117,variable consideration,3.378787878787879
1118,cumulative effect,3.3777777777777778
1119,reasonable possibility,3.375
1120,pending adoption,3.373015873015873
1121,treatment,3.3681318681318677
1122,tumor,3.367924528301887
1123,order,3.362987012987013
1124,table,3.3605200945626477
1125,securities,3.357142857142857
1126,europe japan,3.357142857142857
1127,cash,3.3559814169570266
1128,event,3.3529411764705883
1129,order,3.342897727272727
1130,inability,3.338095238095238
1131,risk,3.3350409836065573
1132,traditional surgery,3.333333333333333
1133,systemic disease,3.333333333333333
1134,trading purpose,3.333333333333333
1135,november holder,3.322222222222222
1136,recognized concurrent,3.3157894736842106
1137,recognized concurrently,3.3157894736842106
1138,adversely affect,3.3125
1139,access,3.3125
1140,developed country,3.3125
1141,developing country,3.3125
1142,redemption date,3.3086956521739133
1143,impairment,3.3
1144,million percentage,3.2956917445714002
1145,component subject,3.2860411899313497
1146,election repay,3.2857142857142856
1147,age,3.2841068917018283
1148,accrued liability,3.2804347826086957
1149,time,3.2800000000000002
1150,damage,3.269230769230769
1151,million research,3.2630830489192264
1152,repaid million,3.2630830489192264
1153,year decrease,3.2512730976284008
1154,credit analysis,3.243333333333333
1155,icc released,3.236842105263158
1156,entire carrying,3.235294117647059
1157,evaluate investment,3.2279999999999998
1158,bifurcation,3.2272727272727275
1159,world sale,3.2238805970149254
1160,government entity,3.2222222222222223
1161,china,3.2142857142857144
1162,small portion,3.2142857142857144
1163,party claim,3.2102272727272725
1164,customer,3.188945290468133
1165,impairment annually,3.185714285714286
1166,le control,3.1739130434782608
1167,commitments,3.173414820473644
1168,company belief,3.171487603305785
1169,company,3.171487603305785
1170,distributor order,3.1606060606060606
1171,backlog criterion,3.1582089552238806
1172,thousand property,3.153038259564891
1173,change,3.1462236533957846
1174,payment increase,3.142945496714341
1175,company,3.1357733175914992
1176,company doe,3.1357733175914992
1177,million reduction,3.1130830489192265
1178,order,3.112987012987013
1179,payment,3.1115384615384616
1180,backlog,3.1082089552238807
1181,prepayment premium,3.0857142857142854
1182,company,3.0659320477502296
1183,company review,3.046487603305785
1184,recorded goodwill,3.041940789473684
1185,thousand information,3.0120585701981053
1186,measure fair,3.011437908496732
1187,infringement indemnification,3.0
1188,company,2.9929161747343564
1189,june,2.9884928849848
1190,company,2.983987603305785
1191,summary judgment,2.9833333333333334
1192,asfollows,2.9827586206896552
1193,company,2.9770431588613406
1194,headcount decrease,2.9770114942528734
1195,case basis,2.974025974025974
1196,table,2.971631205673759
1197,estimated fair,2.9558823529411766
1198,remanded claim,2.9375
1199,company,2.937112603305785
1200,million refer,2.897698433534611
1201,company record,2.8830260648442465
1202,senior,2.872340425531915
1203,indenture holder,2.8671201814058955
1204,product portion,2.8431516936671573
1205,company,2.82624950806769
1206,million decrease,2.8234278765054333
1207,time deposit,2.8184615384615386
1208,thousand accumulated,2.8046511627906976
1209,equipment,2.800865800865801
1210,million increase,2.7944900840951057
1211,closing,2.793103448275862
1212,fair presentation,2.777310924369748
1213,method,2.760869565217391
1214,expired point,2.7115384615384617
1215,time,2.704242424242424
1216,customer increase,2.6925745478662346
1217,policy,2.6923076923076925
1218,world backlog,2.691542288557214
1219,month,2.6883561643835616
1220,backlog,2.6739984289080914
1221,borrowing,2.6666666666666665
1222,estimate,2.6118881118881117
1223,aggregate,2.6037735849056602
1224,income,2.590909090909091
1225,primarily,2.5849056603773586
1226,million compared,2.566337486789049
1227,hospital,2.5555555555555554
1228,accounting,2.5517241379310347
1229,increased,2.5405405405405403
1230,end customer,2.5222786238014665
1231,rate,2.5076923076923077
1232,software,2.5
1233,significant,2.5
1234,modified,2.5
1235,convertible,2.49873417721519
1236,recognition,2.489795918367347
1237,notes,2.4880636604774535
1238,debt,2.4782608695652173
1239,position,2.4782608695652173
1240,backlog,2.4772565742714994
1241,equity,2.457627118644068
1242,current,2.4415584415584415
1243,selling,2.44
1244,fixed,2.411764705882353
1245,price,2.4113475177304964
1246,due,2.3959390862944163
1247,total,2.391304347826087
1248,principal,2.3846153846153846
1249,currency,2.3783783783783785
1250,trade,2.3684210526315788
1251,march,2.3674698795180724
1252,process,2.36
1253,count,2.357142857142857
1254,dilutive,2.3529411764705883
1255,lower,2.3513513513513513
1256,radiation,2.3508771929824563
1257,related,2.3385416666666665
1258,reply,2.3333333333333335
1259,success,2.3333333333333335
1260,gain,2.3333333333333335
1261,remaining,2.3181818181818183
1262,accrual,2.3125
1263,prior,2.3010752688172045
1264,greater,2.3
1265,amortization,2.2962962962962963
1266,account,2.2934782608695654
1267,december,2.2901234567901234
1268,applied,2.2857142857142856
1269,underlying,2.2857142857142856
1270,fee,2.28125
1271,interest,2.2755102040816326
1272,america,2.272727272727273
1273,term,2.263157894736842
1274,assessment,2.260869565217391
1275,facility,2.2580645161290325
1276,resulting,2.2432432432432434
1277,measurement,2.2432432432432434
1278,license,2.242424242424242
1279,condensed,2.230769230769231
1280,offset,2.2247191011235956
1281,conversion,2.2241379310344827
1282,bonus,2.2222222222222223
1283,cost,2.220183486238532
1284,elect,2.2142857142857144
1285,represent,2.2142857142857144
1286,condition,2.212121212121212
1287,issued,2.2045454545454546
1288,observable,2.2
1289,line,2.2
1290,higher,2.1956521739130435
1291,september,2.1904761904761907
1292,held,2.1875
1293,redeemed,2.176470588235294
1294,consisted,2.1739130434782608
1295,item,2.1627906976744184
1296,profit,2.1538461538461537
1297,risk,2.1475409836065573
1298,maturity,2.142857142857143
1299,location,2.142857142857143
1300,expense,2.1419753086419755
1301,service,2.1353383458646618
1302,project,2.1333333333333333
1303,operating,2.1315789473684212
1304,system,2.1288659793814433
1305,loss,2.128205128205128
1306,accuray,2.119047619047619
1307,offering,2.119047619047619
1308,retrospective,2.1176470588235294
1309,office,2.1176470588235294
1310,revenue,2.1171171171171173
1311,performance,2.111111111111111
1312,amount,2.110655737704918
1313,decreased,2.1052631578947367
1314,radiosurgery,2.1041666666666665
1315,benefit,2.097560975609756
1316,differ,2.0869565217391304
1317,lease,2.086206896551724
1318,credit,2.0833333333333335
1319,management,2.08
1320,inventory,2.074074074074074
1321,secured,2.074074074074074
1322,mlc,2.0689655172413794
1323,based,2.0675675675675675
1324,earlier,2.0625
1325,generally,2.0625
1326,large,2.0625
1327,including,2.056603773584906
1328,forward,2.056603773584906
1329,derived,2.0555555555555554
1330,subsidiary,2.054054054054054
1331,general,2.05
1332,specific,2.0476190476190474
1333,balance,2.046511627906977
1334,financing,2.015625
1335,unaudited,2.0
1336,incorporated,2.0
1337,gaap,2.0
1338,good,2.0
1339,basic,2.0
1340,segment,2.0
1341,asset,2.0
1342,input,2.0
1343,directly,2.0
1344,inputs,2.0
1345,hearing,2.0
1346,charge,2.0
1347,loan,2.0
1348,repurchase,2.0
1349,report,2.0
1350,designed,2.0
1351,faster,2.0
1352,clinician,2.0
1353,receipt,2.0
1354,shipped,2.0
1355,place,2.0
1356,material,2.0
1357,sufficient,2.0
1358,deemed,2.0
1359,radixact,2.0
1360,note,1.9915966386554622
1361,equivalent,1.9787234042553192
1362,contract,1.9777777777777779
1363,market,1.9770114942528736
1364,made,1.967741935483871
1365,paid,1.9666666666666666
1366,cowealth,1.9583333333333333
1367,cash,1.951219512195122
1368,year,1.9409282700421941
1369,combination,1.9375
1370,inability,1.9333333333333333
1371,basis,1.9285714285714286
1372,adoption,1.9285714285714286
1373,approximately,1.927710843373494
1374,effective,1.9242424242424243
1375,share,1.92090395480226
1376,deferral,1.9166666666666667
1377,range,1.9130434782608696
1378,tomotherapy,1.91
1379,supplier,1.9090909090909092
1380,estimable,1.9090909090909092
1381,approved,1.9090909090909092
1382,period,1.90625
1383,impairment,1.9
1384,fiscal,1.89375
1385,component,1.891304347826087
1386,disclosure,1.891304347826087
1387,sale,1.890547263681592
1388,monitor,1.8888888888888888
1389,level,1.8888888888888888
1390,request,1.8888888888888888
1391,liquidity,1.8888888888888888
1392,change,1.8839285714285714
1393,contractual,1.8717948717948718
1394,tumor,1.8679245283018868
1395,assets,1.8666666666666667
1396,settlement,1.8666666666666667
1397,payment,1.8615384615384616
1398,asu,1.858974358974359
1399,assumption,1.8571428571428572
1400,reason,1.8571428571428572
1401,assessing,1.8571428571428572
1402,transfer,1.8461538461538463
1403,obligation,1.8421052631578947
1404,sell,1.8333333333333333
1405,variable,1.8333333333333333
1406,order,1.8272727272727274
1407,transaction,1.8225806451612903
1408,security,1.8169014084507042
1409,holders,1.8108108108108107
1410,date,1.808695652173913
1411,statement,1.8053097345132743
1412,body,1.8
1413,criterion,1.8
1414,cyberknife,1.7969924812030076
1415,percentage,1.7826086956521738
1416,expect,1.7777777777777777
1417,party,1.7727272727272727
1418,unable,1.7692307692307692
1419,arbitration,1.7692307692307692
1420,deferred,1.7619047619047619
1421,probable,1.7619047619047619
1422,include,1.76
1423,stockholder,1.75
1424,includes,1.75
1425,belief,1.75
1426,accrued,1.75
1427,factor,1.75
1428,research,1.75
1429,repaid,1.75
1430,icc,1.736842105263158
1431,judgment,1.7333333333333334
1432,matter,1.7333333333333334
1433,included,1.7307692307692308
1434,investment,1.728
1435,issuance,1.7272727272727273
1436,volume,1.7272727272727273
1437,set,1.7222222222222223
1438,treatment,1.7142857142857142
1439,doe,1.7142857142857142
1440,submitted,1.7142857142857142
1441,performed,1.7142857142857142
1442,expiration,1.7142857142857142
1443,fact,1.7142857142857142
1444,fda,1.7142857142857142
1445,address,1.7142857142857142
1446,part,1.7
1447,november,1.7
1448,adjustment,1.6896551724137931
1449,expected,1.6875
1450,arrangement,1.6666666666666667
1451,generated,1.6666666666666667
1452,series,1.6666666666666667
1453,alternative,1.6666666666666667
1454,government,1.6666666666666667
1455,headcount,1.6666666666666667
1456,annum,1.6666666666666667
1457,extinguishment,1.6666666666666667
1458,write,1.6666666666666667
1459,deliver,1.6538461538461537
1460,determined,1.6444444444444444
1461,quarter,1.6413793103448275
1462,table,1.6382978723404256
1463,technology,1.631578947368421
1464,product,1.6288659793814433
1465,obtain,1.625
1466,conform,1.625
1467,review,1.625
1468,commission,1.6229508196721312
1469,holder,1.6222222222222222
1470,award,1.6206896551724137
1471,equipment,1.619047619047619
1472,business,1.6153846153846154
1473,thousand,1.6046511627906976
1474,operation,1.6029411764705883
1475,quality,1.6
1476,reduction,1.6
1477,obtained,1.6
1478,proceeds,1.5806451612903225
1479,awarded,1.5714285714285714
1480,care,1.5714285714285714
1481,signed,1.5714285714285714
1482,depreciation,1.5714285714285714
1483,prepayment,1.5714285714285714
1484,consistent,1.5714285714285714
1485,settled,1.5625
1486,patient,1.5606060606060606
1487,entity,1.5555555555555556
1488,exceed,1.5555555555555556
1489,essential,1.5555555555555556
1490,considers,1.5555555555555556
1491,measure,1.5555555555555556
1492,property,1.5483870967741935
1493,consideration,1.5454545454545454
1494,deposit,1.5384615384615385
1495,upgrade,1.5357142857142858
1496,liability,1.5304347826086957
1497,goodwill,1.5263157894736843
1498,considered,1.5263157894736843
1499,recorded,1.515625
1500,premium,1.5142857142857142
1501,million,1.5130830489192264
1502,impact,1.5087719298245614
1503,age,1.5063291139240507
1504,japan,1.5
1505,typically,1.5
1506,identical,1.5
1507,readily,1.5
1508,provision,1.5
1509,estimated,1.5
1510,remanded,1.5
1511,counterclaim,1.5
1512,application,1.5
1513,china,1.5
1514,infringement,1.5
1515,provide,1.5
1516,indemnification,1.5
1517,qibs,1.5
1518,bank,1.5
1519,redemption,1.5
1520,guidance,1.5
1521,reported,1.5
1522,uncertainty,1.5
1523,treat,1.5
1524,treating,1.5
1525,deal,1.5
1526,evaluate,1.5
1527,lessee,1.5
1528,exposure,1.5
1529,asfollows,1.5
1530,released,1.5
1531,decline,1.5
1532,shift,1.5
1533,hiring,1.5
1534,presented,1.4827586206896552
1535,june,1.4754098360655739
1536,installation,1.4666666666666666
1537,point,1.4615384615384615
1538,record,1.4615384615384615
1539,fair,1.4558823529411764
1540,dismissal,1.4545454545454546
1541,delivery,1.4545454545454546
1542,letter,1.4545454545454546
1543,pending,1.4444444444444444
1544,earnings,1.4444444444444444
1545,option,1.4411764705882353
1546,met,1.4375
1547,claim,1.4375
1548,adopt,1.4285714285714286
1549,impaired,1.4285714285714286
1550,required,1.4242424242424243
1551,company,1.421487603305785
1552,amendment,1.4210526315789473
1553,determination,1.4166666666666667
1554,denominated,1.4166666666666667
1555,acquisition,1.4166666666666667
1556,collection,1.411764705882353
1557,customer,1.4111675126903553
1558,information,1.4074074074074074
1559,number,1.4074074074074074
1560,pay,1.4047619047619047
1561,sold,1.4
1562,recovery,1.4
1563,prejudice,1.4
1564,ruling,1.4
1565,noted,1.4
1566,exist,1.4
1567,subject,1.394736842105263
1568,dollar,1.3870967741935485
1569,estimate,1.3846153846153846
1570,refer,1.3846153846153846
1571,fund,1.3846153846153846
1572,effect,1.3777777777777778
1573,allowance,1.375
1574,reasonable,1.375
1575,cancellation,1.358974358974359
1576,backlog,1.3582089552238805
1577,securities,1.3571428571428572
1578,event,1.3529411764705883
1579,distributor,1.3333333333333333
1580,purpose,1.3333333333333333
1581,refund,1.3333333333333333
1582,amended,1.3333333333333333
1583,present,1.3333333333333333
1584,limited,1.3333333333333333
1585,expectation,1.3333333333333333
1586,surgery,1.3333333333333333
1587,disease,1.3333333333333333
1588,utilization,1.3333333333333333
1589,world,1.3333333333333333
1590,base,1.3333333333333333
1591,customary,1.3333333333333333
1592,presentation,1.3214285714285714
1593,recognized,1.3157894736842106
1594,affect,1.3125
1595,october,1.3125
1596,covenant,1.3125
1597,improve,1.3125
1598,country,1.3125
1599,decrease,1.3103448275862069
1600,filed,1.2857142857142858
1601,added,1.2857142857142858
1602,election,1.2857142857142858
1603,annually,1.2857142857142858
1604,increase,1.2814070351758795
1605,time,1.28
1606,adopted,1.2727272727272727
1607,damage,1.2692307692307692
1608,discount,1.2678571428571428
1609,result,1.2622950819672132
1610,received,1.25
1611,demand,1.25
1612,summary,1.25
1613,expired,1.25
1614,indenture,1.2448979591836735
1615,carrying,1.2352941176470589
1616,require,1.2272727272727273
1617,make,1.2272727272727273
1618,purchase,1.2153846153846153
1619,portion,1.2142857142857142
1620,permitted,1.2
1621,accumulated,1.2
1622,revise,1.2
1623,complex,1.2
1624,discussed,1.1875
1625,measured,1.1818181818181819
1626,commitments,1.1818181818181819
1627,control,1.173913043478261
1628,dilution,1.1666666666666667
1629,analysis,1.16
1630,excluded,1.1578947368421053
1631,delay,1.1428571428571428
1632,cleared,1.1428571428571428
1633,convert,1.119047619047619
1634,end,1.1111111111111112
1635,life,1.1
1636,contingency,1.0909090909090908
1637,april,1.0588235294117647
1638,compared,1.0532544378698225
1639,case,1.0454545454545454
1640,standard,1.0425531914893618
1641,january,1.0285714285714285
1642,addition,1.027027027027027
1643,august,1.0178571428571428
1644,par,1.0
1645,operations,1.0
1646,delaware,1.0
1647,conduct,1.0
1648,principles,1.0
1649,consolidation,1.0
1650,eliminated,1.0
1651,prepared,1.0
1652,accordance,1.0
1653,sec,1.0
1654,opinion,1.0
1655,read,1.0
1656,conjunction,1.0
1657,form,1.0
1658,contracts,1.0
1659,supersede,1.0
1660,transferred,1.0
1661,reflects,1.0
1662,achieve,1.0
1663,allocating,1.0
1664,defined,1.0
1665,providing,1.0
1666,selected,1.0
1667,evaluating,1.0
1668,estimates,1.0
1669,preparation,1.0
1670,conformity,1.0
1671,recoverability,1.0
1672,risks,1.0
1673,deposited,1.0
1674,experienced,1.0
1675,exposed,1.0
1676,represented,1.0
1677,collateralized,1.0
1678,charged,1.0
1679,find,1.0
1680,source,1.0
1681,majority,1.0
1682,responsible,1.0
1683,acceptance,1.0
1684,functionality,1.0
1685,expensed,1.0
1686,incurred,1.0
1687,computed,1.0
1688,reconciliation,1.0
1689,numerator,1.0
1690,denominator,1.0
1691,calculation,1.0
1692,vesting,1.0
1693,computation,1.0
1694,inclusion,1.0
1695,intent,1.0
1696,settle,1.0
1697,vary,1.0
1698,fluctuation,1.0
1699,operates,1.0
1700,continue,1.0
1701,indicator,1.0
1702,identify,1.0
1703,hierarchy,1.0
1704,corroborated,1.0
1705,classified,1.0
1706,relied,1.0
1707,determine,1.0
1708,indication,1.0
1709,recover,1.0
1710,inthousands,1.0
1711,contingencies,1.0
1712,ordinary,1.0
1713,involved,1.0
1714,respect,1.0
1715,individually,1.0
1716,prove,1.0
1717,incorrect,1.0
1718,theory,1.0
1719,dismiss,1.0
1720,motion,1.0
1721,specificity,1.0
1722,favor,1.0
1723,affirmed,1.0
1724,misappropriated,1.0
1725,answer,1.0
1726,february,1.0
1727,correction,1.0
1728,ground,1.0
1729,accrue,1.0
1730,likelihood,1.0
1731,assigned,1.0
1732,proprietary,1.0
1733,indemnify,1.0
1734,replace,1.0
1735,modify,1.0
1736,terminate,1.0
1737,aware,1.0
1738,offered,1.0
1739,rule,1.0
1740,deducting,1.0
1741,amortized,1.0
1742,arrears,1.0
1743,mature,1.0
1744,converted,1.0
1745,close,1.0
1746,circumstance,1.0
1747,occurrence,1.0
1748,remainder,1.0
1749,excess,1.0
1750,represents,1.0
1751,connection,1.0
1752,entitled,1.0
1753,redeem,1.0
1754,options,1.0
1755,accreted,1.0
1756,began,1.0
1757,translated,1.0
1758,affiliate,1.0
1759,book,1.0
1760,ensure,1.0
1761,maintain,1.0
1762,affirmative,1.0
1763,discussion,1.0
1764,results,1.0
1765,sufficiency,1.0
1766,ability,1.0
1767,mitigate,1.0
1768,meet,1.0
1769,identified,1.0
1770,word,1.0
1771,filing,1.0
1772,investor,1.0
1773,markets,1.0
1774,aim,1.0
1775,enables,1.0
1776,treated,1.0
1777,desire,1.0
1778,discretion,1.0
1779,depends,1.0
1780,delivered,1.0
1781,localized,1.0
1782,leukemia,1.0
1783,lymphoma,1.0
1784,organ,1.0
1785,efficient,1.0
1786,seriessystems,1.0
1787,dependent,1.0
1788,shipment,1.0
1789,regularly,1.0
1790,doctor,1.0
1791,ease,1.0
1792,configuration,1.0
1793,degree,1.0
1794,daily,1.0
1795,shape,1.0
1796,capable,1.0
1797,head,1.0
1798,widely,1.0
1799,decade,1.0
1800,capture,1.0
1801,influenced,1.0
1802,contact,1.0
1803,prepare,1.0
1804,stand,1.0
1805,cover,1.0
1806,recognizable,1.0
1807,counted,1.0
1808,incorporates,1.0
1809,assured,1.0
1810,passed,1.0
1811,cancelled,1.0
1812,remove,1.0
1813,adapt,1.0
1814,accommodate,1.0
1815,dollars,1.0
1816,sum,1.0
1817,revision,1.0
1818,introduction,1.0
1819,cancellations,1.0
1820,difficult,1.0
1821,forecast,1.0
1822,minimize,1.0
1823,timing,1.0
1824,enter,1.0
1825,reduce,1.0
1826,expressed,1.0
1827,don,1.0
1828,resulted,1.0
1829,started,1.0
1830,attributable,1.0
1831,strengthen,1.0
1832,comparison,1.0
1833,unavailable,1.0
1834,distribution,1.0
1835,dividend,1.0
1836,anticipate,1.0
1837,repatriate,1.0
1838,summarized,1.0
1839,accretion,1.0
1840,release,1.0
1841,restriction,1.0
1842,collected,1.0
1843,invoicing,1.0
1844,utilized,1.0
1845,prepaids,1.0
1846,half,1.0
1847,footnotes,1.0
1848,progress,1.0
1849,obtaining,1.0
1850,insufficient,1.0
1851,satisfy,1.0
1852,seek,1.0
1853,raised,1.0
1854,restrict,1.0
1855,scope,1.0
1856,reclassified,1.0
1857,aspect,1.0
1858,classification,1.0
1859,depend,1.0
1860,finance,1.0
1861,obligor,1.0
1862,augment,1.0
1863,collateral,1.0
1864,moody,1.0
1865,rating,1.0
1866,baa,1.0
1867,lawsuit,1.0
1868,stipulation,1.0
1869,dealt,1.0
1870,rejected,1.0
1871,published,1.0
1872,repayable,1.0
1873,substantially,1.0
1874,accelerated,1.0
1875,tradeshows,1.0
1876,begin,1.0
1877,clarification,1.0
1878,ass,1.0
1879,manage,1.0
1880,speculative,1.0
1881,designated,1.0
1882,intended,1.0
1883,intend,1.0
1884,insignificant,1.0
1885,liabilities,1.0
1886,evaluated,1.0
1887,corroboration,1.0
1888,simpler,1.0
1889,scale,1.0
1890,length,1.0
1891,completion,1.0
1892,clarifies,1.0
1893,territory,1.0
1894,contained,1.0
1895,stated,1.0
1896,reduced,1.0
1897,negotiated,1.0
1898,function,1.0
